Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Papers of interest

Pelican no longer funds research into prostate cancer.

 

Below Pelican has listed a selection of papers that reflect the areas of research that we have been involved in and continue to support. Where possible the links to the abstracts are included for further information.

International multicentre prospective study on microwave ablation of liver tumours: preliminary results. Lloyd DM,Lau KN, Welsh F, Lee KF, Sherlock DJ, Choti MA, Martinie JB, Iannitti DA, on behalf of the International Microwave Tumour Ablation Group; HPB 2011; 13:579-85.

Long-term survival following delayed presentation and resection of colorectal liver metastases. P.J.Swan, F.K.S.Welsh, K.Chandrakumaran and M.Rees. British Journal of Surgery. May 19, 2011; DOI: 10.1002/bjs.7527.

Open liver resection for colorectal metastases: better short- and long-term outcomes in patients potentially suitable for laparoscopic liver resection.Welsh FKS. Tekkis PP, John TG, Rees M. HPB 2010, 12(3):188-94.

Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.TR O’Rourke, FKS Welsh, PP Tekkis, N Lyle, A Mustajab, TG John, D Peppercorn, M Rees. European Journal of Surgical Oncology 2009; 35: 1085-1091.

The international position on laparoscopic liver surgery: The Louisville Statement, 2008.Buell JF. Cherqui D. Geller DA. O’Rourke N. Iannitti D. Dagher I. Koffron AJ. Thomas M. Gayet B. Han HS. Wakabayashi G. Belli G. Kaneko H. Ker CG. Scatton O. Laurent A. Abdalla EK. Chaudhury P. Dutson E. Gamblin C. D’Angelica M. Nagorney D. Testa G. Labow D. Manas D. Poon RT. Nelson H. Martin R. Clary B. Pinson WC. Martinie J. Vauthey JN. Goldstein R. Roayaie S. Barlet D. Espat J. Abecassis M. Rees M. Fong Y. McMasters KM. Broelsch C. Busuttil R. Belghiti J. Strasberg S. Chari RS. World Consensus Conference on Laparoscopic Surgery. Annals of Surgery 2009; 250(5):825-30.

Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.JM Blazeby, P Fayers, T Conroy, O Sezer, J Ramage, M Rees. Br J Surg 2009; 96: 291-298.

Evaluation of long-term survival following hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Rees M, Tekkis PP, Welsh FK, O’Rourke TR, John TG. Annals of Surgery 2008; 247:125-135.

Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases.Thomas R O`Rourke, Fenella Welsh, Paris Tekkis, Shinn Yeung, Jonathan Fawcett, Steven Lynch,Russell Strong, Daryll Wall, Timothy G John, Myrddin Rees. Annals of Surgical Oncology 2008; 15(1): 207-218.

Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer – an aid to clinical decision-making. F K S Welsh, P Tekkis, T R O`Rourke, T G John, M Rees. Annals of Surgical Oncology 2008; 17(1): 3-13.

Elective intra-aortic balloon counterpulsation during a high-risk liver resection. Oliver J C, Welsh F K S, Bell J, Bishop A J, Glover J, Rees M. Anaesthesia 2008; 63: 1365-8.

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing.FKS Welsh, HS Tilney, P Tekkis, TG John, M Rees. British Journal of Cancer 2007, 96(7):1037-42.

A meta-analysis of clinical outcome following first and second liver resection for colorectal metastases. A Antoniou, R Lovegrove, P Tekkis, H Tilney, A Darzi, A Heriot, T John, M Rees F Welsh. Surgery 2007, 141(1):9-18.

Laparoscopic staging in selected patients with colorectal liver metastases as a prelude to liver resection. S A Pilkington, M Rees, D Peppercorn, TG John. HPB 2007; 9: 58-63

Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long term survival. IM Shaw, M Rees, FKS Welsh, S Bygrave, TG John. British Journal of Surgery 2006, 93(4):457-64.

Hepatic resection for malignant melanoma. Crook TB. Jones OM. John TG. Rees M. European Journal of Surgical Oncology 2006, 32(3):315-7.

Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection.Jones OM. Rees M. John TG. Bygrave S. Plant G. British Journal of Surgery 2005, 92(9):1165-8.

Biopsy of potentially operable hepatic colorectal metastases is not useless but dangerous. Jones OM. Rees M. John TG. Bygrave S. Plant G. British Medical Journal 2004, 329(7473):1045-6.

Cells for bioartificial liver devices: The human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia.Demetra Mavri-Damelin, Leonard H Damelin, Simon Eaton, Myrddin Rees, Claire Selden, Humphrey JF Hodgson. Biotechnology & Bioengineering; 99(3): 644-651.

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy